off
FDA clears drug for leading form of cystic fibrosis – Modern Healthcare
The patient population that can be helped by the drug is small, though, and the cost is high: about $311,000 per patient, per year. The actual or net price of Orkambi will be lower depending on the discounts and rebates offered to insurance companies.
Posted On Jul 03 2015
